Outset Medical, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
10-K: Outset Medical Reports Fiscal Year 2024 Results, Navigates Market Challenges and Focuses on Growth
Outset Medical's 2024 10-K filing reveals a company navigating market headwinds while focusing on expanding its Tablo Hemodialysis System's reach and improving financial performance.
NASDAQ
Outset Medical updates its 2020 Equity Incentive Plan and details executive compensation and severance agreements, including clawback provisions.